Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Oct 31, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2005.074542v1
97/2/344    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, H. L.F.
Right arrow Articles by Friedman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, H. L.F.
Right arrow Articles by Friedman, R.
Related Collections
Right arrow Geography
Right arrow HIV/AIDS
Right arrow African Americans/Blacks
Right arrow Other Race/Ethnicity
Right arrow Drugs
Right arrow Urban Health
February 2007, Vol 97, No. 2 | American Journal of Public Health 344-352
© 2007 American Public Health Association
DOI: 10.2105/AJPH.2005.074542

RESEARCH AND PRACTICE

Residential Segregation and Injection Drug Use Prevalence Among Black Adults in US Metropolitan Areas

Hannah L.F. Cooper, ScD, Samuel R. Friedman, PhD, Barbara Tempalski, PhD and Risa Friedman, MPH

At the time of this study, Hannah L. F. Cooper was with the Medical and Health Research Association of New York City, Inc, New York, NY, the National Development and Research Institutes, Inc, New York, and the Columbia Mailman School of Public Health, New York. Samuel R. Friedman was with the National Development and Research Institutes, Inc, and the Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. Barbara Tempalski and Risa Friedman were with the National Development and Research Institutes, Inc.

Correspondence: Requests for reprints should be sent to Hannah L.F. Cooper, ScD, Postdoctoral Fellow, NDRI, 71 West 23rd St, 8th Floor, New York, NY 10010 (e-mail: cooper{at}ndri.org).

Objectives. We analyzed the relations of two 1990 dimensions of racial residential segregation (isolation and concentration) with 1998 injection drug use prevalence among Black adult residents of 93 large US metropolitan statistical areas (MSAs).

Methods. We estimated injection drug use prevalence among Black adults in each MSA by analyzing 3 databases documenting injection drug users’ encounters with the health care system. Multiple linear regression methods were used to investigate the relationship of isolation and concentration to the natural logarithm of Black adult injection drug use prevalence, controlling for possible confounders.

Results. The median injection drug use prevalence was 1983 per 100000 Black adults (interquartile range: 1422 to 2759 per 100000). The median isolation index was 0.48 (range: 0.05 to 0.84): in half the MSAs studied, the average Black resident inhabited a census tract where 48% or more of the residents were Black. The multiple regression model indicates that an increase of 0.50 in the isolation index was associated with a 23% increase in injection drug use prevalence among Black adults. Concentration was unrelated to the outcome.

Conclusions. Residential isolation is positively related to Black injection drug use prevalence in MSAs. Research into the pathways linking isolation to injection drug use is needed.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Public Health Association